Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:603108's PB Ratio is ranked better than 61.86% of 194
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.025
vs SHSE:603108: 1.62
During the past 12 months, Shanghai Runda Medical Technology Co's average Book Value Per Share Growth Rate was -13.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -2.20% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 3.70% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 11.30% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Shanghai Runda Medical Technology Co was 61.60% per year. The lowest was -2.20% per year. And the median was 11.25% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Shanghai Runda Medical Technology Co PB Ratio Related Terms
Shanghai Runda Medical Technology Co PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Runda Medical Technology Co PB Ratio Chart
SHSE:603108 vs TMO, DHR, IDXX: PB Ratio Comparison
For the Diagnostics & Research subindustry, Shanghai Runda Medical Technology Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Runda Medical Technology Co PB Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Shanghai Runda Medical Technology Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Shanghai Runda Medical Technology Co's PB Ratio falls into.
Shanghai Runda Medical Technology Co PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Shanghai Runda Medical Technology Co (SHSE:603108) has a PB Ratio of 1.62 as of Aug. 01, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Shanghai Runda Medical Technology Co and its competitors. This is 29% below median its historical median of 2.29. Over the past decade, Shanghai Runda Medical Technology Co's PB Ratio has ranged from 1.43 to 11.28. According to the industry distribution chart, Shanghai Runda Medical Technology Co ranks #74 out of 194 companies in the Medical Diagnostics & Research industry, placing it in the top 38.1%.
Is Shanghai Runda Medical Technology Co's PB Ratio too high?
Shanghai Runda Medical Technology Co's current PB Ratio of 1.62 is 29% below median its 10-year median of 2.29. Over the past 10 years, this metric has ranged from a low of 1.43 to a high of 11.28. The Medical Diagnostics & Research industry median PB Ratio is 2.03. Shanghai Runda Medical Technology Co's value of 1.62 is 20% below this industry median. Based on the distribution chart, Shanghai Runda Medical Technology Co ranks #74 out of 194 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Shanghai Runda Medical Technology Co has a GF Score™ of 39/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Shanghai Runda Medical Technology Co's PB Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Shanghai Runda Medical Technology Co ranks #74 out of 194 companies for PB Ratio. This puts Shanghai Runda Medical Technology Co in the upper half of its industry. The industry median PB Ratio is 2.03. Shanghai Runda Medical Technology Co's value of 1.62 is 20% below this benchmark. Historically, Shanghai Runda Medical Technology Co's own PB Ratio has ranged from 1.43 to 11.28 over the past decade. While the company's 10-year median is 2.29 vs. the industry median of 2.03, Shanghai Runda Medical Technology Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Diagnostics & Research company?
The median PB Ratio among Medical Diagnostics & Research companies is 2.03, based on 194 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Runda Medical Technology Co's current PB Ratio of 1.62 is 20% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Shanghai Runda Medical Technology Co and its competitors. For the Medical Diagnostics & Research industry, the median PB Ratio is 2.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Runda Medical Technology Co's current PB Ratio is 1.62, which is 29% below median its own 10-year median of 2.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Runda Medical Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Runda Medical Technology Co (SHSE:603108) is currently considered Possible Value Trap. The stock's GF Value™ is ¥17.89, compared to a current price of ¥10.01 — trading 44% below its estimated fair value. The current PB Ratio is 1.62, which is 29% below median its 10-year median of 2.29 and 20% below the Medical Diagnostics & Research industry median of 2.03. Shanghai Runda Medical Technology Co's overall GF Score™ is 39/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Shanghai Runda Medical Technology Co (SHSE:603108), the current PB Ratio is 1.62 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Runda Medical Technology Co (SHSE:603108) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Runda Medical Technology Co stock appears to be undervalued.
The current stock price of ¥10.01 is trading 44% below its estimated GF Value™ of ¥17.89.
GuruFocus considers Shanghai Runda Medical Technology Co to be Possible Value Trap.
Key valuation signals for SHSE:603108:
PB Ratio: 1.62 (29% below median its 10-year median of 2.29)
GF Value™: ¥17.89 vs. price of ¥10.01 (44% below fair value)
Industry Position: 20% below the Medical Diagnostics & Research median (#74 of 194)
No single metric tells the full story. See the SHSE:603108 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Runda Medical Technology Co Ltd is a medical laboratory integrated service provider based in East China. The company provides in-vitro diagnostic products and professional technical support to various medical laboratories.
39GF Score
Get the complete analysis for SHSE:603108
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603108 has been successfully added to your 
